As the healthcare and pharmaceutical industries rush to tackle a wide range of COVID-19 challenges, from developing treatments and sourcing medical supplies to mitigating outbreaks and racing towards a vaccine, the use of AI-driven solutions is accelerating rapidly.

News about artificial intelligence (AI) efforts in healthcare breaks daily: Hospitals in the U.K. are turning to AI to help triage COVID-19 patients.

The CDC hosts an AI-driven bot on its website to help screen for coronavirus infections.

The FDA recently cleared several AI-driven devices to screen COVID-19 patients for heart problems.

This need for AI’s algorithmic modeling power is potentially reshaping the future of a highly regulated industry that has historically been conservative about implementing new technologies.

Read More